Academic Content and Language Evaluation of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (6327)
All Articles published online
|
Publishing Process of This Article
|
Aug 26, 2014 (publication date) through May 15, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Cardiology
ISSN
1949-8462
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Mathew R. Pulmonary hypertension and metabolic syndrome: Possible connection, PPARγ and Caveolin-1. World J Cardiol 2014; 6(8): 692-705 [PMID: 25228949 DOI: 10.4330/wjc.v6.i8.692] |
|---|---|
| URL: | https://www.wjgnet.com/1949-8462/full/v6/i8/692.htm |
| Number | Citing Articles |
| 1 |
Hongyan Peng, Yunbin Xiao, Xicheng Deng, Jingfei Luo, Chenliang Hong, Xuping Qin. The Warburg effect: A new story in pulmonary arterial hypertension. Clinica Chimica Acta 2016; 461: 53 doi: 10.1016/j.cca.2016.07.017
|
| 2 |
Gusty Rizky Teguh Ryanto, Ratoe Suraya, Tatsuya Nagano. Mitochondrial Dysfunction in Pulmonary Hypertension. Antioxidants 2023; 12(2): 372 doi: 10.3390/antiox12020372
|
| 3 |
Yu G Birulina, V V Ivanov, E E Buyko, V V Bykov, A V Nosarev, V S Gusakova, S V Gusakova. Pulmonary vascular smooth muscle contraction in the rat model of metabolic syndrome. IOP Conference Series: Earth and Environmental Science 2020; 548(4): 042036 doi: 10.1088/1755-1315/548/4/042036
|
| 4 |
Norbert F. Voelkel, Rasa Tamosiuniene, Mark R. Nicolls. Challenges and opportunities in treating inflammation associated with pulmonary hypertension. Expert Review of Cardiovascular Therapy 2016; 14(8): 939 doi: 10.1080/14779072.2016.1180976
|
| 5 |
Sophie Herbert, Robert M. R. Tulloh. Cardiovascular Genetics and Genomics. 2018; : 741 doi: 10.1007/978-3-319-66114-8_26
|
| 6 |
Xutong Sun, Qing Lu, Manivannan Yegambaram, Sanjiv Kumar, Ning Qu, Anup Srivastava, Ting Wang, Jeffrey R. Fineman, Stephen M. Black. TGF-β1 attenuates mitochondrial bioenergetics in pulmonary arterial endothelial cells via the disruption of carnitine homeostasis. Redox Biology 2020; 36: 101593 doi: 10.1016/j.redox.2020.101593
|
| 7 |
Yohei Mineharu, Susumu Miyamoto. RNF213 and GUCY1A3 in Moyamoya Disease: Key Regulators of Metabolism, Inflammation, and Vascular Stability. Frontiers in Neurology 2021; 12 doi: 10.3389/fneur.2021.687088
|
| 8 |
Mirolyuba Ilieva, Shizuka Uchida. Potential Involvement of LncRNAs in Cardiometabolic Diseases. Genes 2023; 14(1): 213 doi: 10.3390/genes14010213
|
| 9 |
Kirsten B. Dorschel, John E. Wanebo. Physiological and pathophysiological mechanisms of the molecular and cellular biology of angiogenesis and inflammation in moyamoya angiopathy and related vascular diseases. Frontiers in Neurology 2023; 14 doi: 10.3389/fneur.2023.661611
|
| 10 |
Dong‐xin Sui, Hui‐min Zhou, Feng Wang, Ming Zhong, Wei Zhang, Yun Ti. Cell death‐inducing DFF45‐like effector C gene silencing alleviates pulmonary vascular remodeling in a type 2 diabetic rat model. Journal of Diabetes Investigation 2018; 9(4): 741 doi: 10.1111/jdi.12768
|
| 11 |
Suvasini Lakshmanan, Matthew Jankowich, Wen‐Chih Wu, Siddique Abbasi, Alan R Morrison, Gaurav Choudhary. Association of plasma adiponectin with pulmonary hypertension, mortality and heart failure in African Americans: Jackson Heart Study. Pulmonary Circulation 2020; 10(4): 1 doi: 10.1177/2045894020961242
|
| 12 |
Julie A Dillard, Claire Murray, Amit A Mathur. New Therapeutic Targets in Neonatal Pulmonary Hypertension. Newborn 2022; 1(1): 158 doi: 10.5005/jp-journals-11002-0015
|